Insider · CIK 0001486429
Elan Ezickson
Files at MRNS (MARINUS PHARMACEUTICALS, INC.). First filing Jan 23, 2025, latest Jan 23, 2025.
In brief
Elan Ezickson files SEC Form 4 as director at MRNS (MARINUS PHARMACEUTICALS, INC.). Since Jan 23, 2025, Elan Ezickson has reported 0 open-market buys worth $0 and 1 open-market sell worth $864, the latest filed on Jan 23, 2025.
A track record needs three past buys with six months of prices behind them; Elan Ezickson has 0, so none is measured yet.
The newest scored trade: sold $864 of MRNS on Jan 21, 2025, filed Jan 23, 2025, scored 8 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | MARINUS PHARMACEUTICALS, INC. | $864 1,600 shares | -13% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -8,600 | $0.55 | $4,730 | 2,300 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -2,300 | $0.55 | $1,265 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,200 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,375 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Jan 21, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,600 | $0.54 | $864 | 10,900 | Jan 23, 2025 |
Questions about Elan Ezickson
Answered from the filings on this page, as of the latest one.
Is Elan Ezickson buying or selling?
Not in the last 12 months. Elan Ezickson's latest open-market trade on SEC Form 4 was sold $864 of MRNS on Jan 21, 2025.
How did Elan Ezickson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elan Ezickson has 0.
Where does Elan Ezickson file Form 4?
Elan Ezickson has filed Form 4 at MRNS (MARINUS PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.